Why the study?
To develop a set of quality indicators for evaluating the care and outcomes of atherosclerotic cardiovascular disease prevention.
Key points are not available for this paper at this time.
Design
Quality indicator development using systematic review and a modified Delphi method
No takes yet. Share an insight, caveat, or question.
QIs enable standardized ASCVD prevention assessment; leaves open real-world validation and outcome impact.
Aktaa et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: